He continued his Post Doc research in Peking University, School of Pharmaceutical Sciences
His research interests focus on mechanism-based PK/PD modeling and simulation for anti-cancer drugs, and quantitative systems pharmacology (QSP) modeling for mechanisms of tumor immunity and immunotherapies.
He was involved in one project funded by the National Natural Science Foundation of China and one project funded by the Beijing Natural Science Foundation. He also participated in multiple collaborative research projects with various companies.
He has published two SCI papers as the first author in Life Sci. and J Pharm Sci., as well as four papers in core journals. Additionally, he has contributed as the second author or co-author to multiple SCI publications.
2023年博士毕业于北京大学药学院。
同年进入北京大学药学院从事博士后。
主要研究方向为抗肿瘤药物基于机制的PK/PD研究和肿瘤免疫机制、免疫治疗相关的定量系统药理学模型化研究。
分别参与国家自然科学基金、北京市自然科学基金各一项。参与多项企业合作研究项目。
以第一作者于Life Sci.、J Pharm Sci.发表SCI论文2篇，核心期刊4篇，以第二作者或参与发表SCI文章多篇。